Anti-VEGF side effects
A number of anti-VEGF-A therapies are now being used to treat eye diseases including wet macular degeneration, diabetic macular oedema and retinopathy of prematurity. A recent study raises concerns about the effects of continuous inhibition of intraocular VEGF on the ciliary body. The researchers looked at VEGF-A expression during ciliary body development in a mouse model. This confirmed that VEGF-A plays a key role at the onset of ciliary process formation. Neutralisation of systemic VEGF-A produced thinning of the non-pigmented epithelium, vacuolization of the pigmented epithelium, loss of capillary fenestrations and thrombosis. These changes were associated with impaired ciliary body function, as evidenced by decreased intraocular pressure. The researchers conclude that VEGF-A has an important role in ciliary body homeostasis and so the potential for undesired off-target effects should be considered with the chronic use of anti– VEGF-A therapies.
KM Ford et al., Investigative Ophthalmology & Visual Science, “Expression and Role of VEGF-A in the Ciliary Body,†November 2012 53:7520-7527.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.